Auditory event-related cerebral potentials (P300) in hepatic Encephalopathy - Topographic distribution and correlation with clinical and psychometric assessment

Hepato-Gastroenterology

Volumn 44, Issue 16, 1997, Pages 1002-1012

  Hollerbach, Stephan ^a   Kullmann, Frank ^a   Fründ, Rüdiger ^a   Lock, Guntram ^a   Geissler, Angela ^a   Schölmerich, Jürgen ^a   Holstege, Axel ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Acoustic event related potentials; Hepatic Encephalopathy; Liver cirrhosis; Psychometric tests; Topographic recordings

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; EVOKED AUDITORY RESPONSE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LATENT PERIOD; LIVER CIRRHOSIS; LIVER FUNCTION; LONGITUDINAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOMETRY;

ADULT; AGE FACTORS; AGED; CEREBRAL CORTEX; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PSYCHOMETRICS; SENSITIVITY AND SPECIFICITY;

EID: 0030849686     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Sherlock S, Dooley J: Hepatic Encephalopathy. In: Sherlock S, Dooley J, eds.: Diseases of the Liver and Biliary System. Oxford: Blackwell Scientific Publications 1993:86-99.
2. Mousseau DD, Butterworth R: Current theories on the pathogenesis of hepatic encephalopathy. Proceedings of the Society for Experimental Biology and Medicine 1994; 206:329-344.
3. Holm E, Thiele H, Wolpert EM, Hein ME, Reimann-Wehrle B: Neurologische und psychiatrische Symptome bei akuten und chronischen Leberkrankheiten. Therapiewoche 1980; 30:4790-4806.
4. Parsons-Smith B, Summerskill W, Dawson A, Sherlork S: The Electroencephalograph in liver disease. Lancet 1957;ii:867-871.
5. Schomerus H, Hamster W, Blunck H, Reinhard U, Mayer K, Dölle W. Latent portosystemic encephalopathy. Dig Dis Sci 1981, 26:622-630.
6. Conn HO: Trailmaking and number-connnection tests in the assessment of mental state in portal systemic encephalopathy. Dig Dis Sci 1977; 22:541-550.
7. Editorial: Hepatic encephalopathy today. Lancet 1984, i:489-491.
8. Ferenci P, Schäfer DF, Kleinberger G, Hoofnagle JH, Jones EA: Serum levels of gamma aminobutyric acid-like activity in acute and chronic hepatocellular disease. Lancet 1983, ii:811-813.
9. Schaefer D, Fowler J, Brody L, Jones EA: Hepatic coma and inhibitory neurotransmission: the enteric bacterial flora as a source of gamma-aminobutyric acid. Gastroenterology 1980, 79:1052-1053.
10. Roberts E: The establishment of GABA as a neurotransmitter in GABA- and Benzodiazepine receptors. In: Squires R, ed. Hepatic Encephalopathy and Metabolic Nitrogen Exchange. Boca Raton, Ann Arbor: CRC Boston press 1988, 1:1-22.
11. Hamill O, Bormann J, Sakmann B: Activation of multiple conductance state chloride channels in spinal neurons by glycine and GABA. Nature 1983, 305:805-808.
12. Martin H, Voss K, Hufnagl P, Wack R, Wassilew G: Morphometric and densitometric investigations of protoplasmic astrocytes and neurons in hepatic encephalopathy. Exp Pathol 1987, 32:198-237.
13. Matos L, Camilo ME, Pinto Correia J, Alves C, Garcia C, Paiva T et al. Subclinical portal-systemic encephalopathy. In: Advances in Hepatic Encephalopathy and Urea Cycle Diseases. Basel: Karger 1984:442-453.
14. Kullmann F, Hollerbach S, Holstege A, Schölmerich J: Subclinical hepatic encephalopathy: the diagnostic value of evoked potentials. J Hepatol 1995, 22:101-110.
15. Weissenborn K, Scholz M, Hinrichs H, Wiltfang J, Schmidt FW, Künkel H: Neurophysiological assessment of early hepatic encephalopathy. Electroenc Clin Neurophys 1990; 75:289-295.
16. Kügler CF, Lotterer E, Petter J, Wensing G, Taghavy A, Hahn E, Fleig W: Visual Event-Related P300 Potentials in Early Portosystemic Encephalopathy. Gastroenterology 1992; 103:302-310.
17. Davies MG, Rowan MJ, MacMathina P, Keeling PWN, Weir DG, Feely J: The auditory P300 event related potential: an objective marker of the encephalopathy of chronic liver disease. Hepatology 1990; 12:688-694.
18. Van der Rijt C, Schalm SW: Quantitative EEG analysis and evoked potentials to measure (latent) hepatic encephalopathy. J Hepatol 1992; 14:141-142.
19. Levy LJ, Bolton RP, Losowsky MS: The visual evoked potential in clinical hepatic encephalopathy in acute and chronic liver disease. Hepatogastroenterology 1990, 37:66-73 (Suppl. 2).
20. Tarter RE, Scalabassi RJ, Sandford SL, Hays AL, Carra JP, van Thiel DH: Relationship between hepatic injury status and event related potentials. Clin Electroencephalogr 1987; 18:15-19.
21. Yang SS, Chu NS, Liaw YF: Somatosensory evoked potentials in hepatic encephalopathy. Gastroenterology 1985; 59:625-630.
22. Matos L, Fred A, Cravo M, Camilo ME, Paiva T: Mapping of EEG and EP in subclinical hepatic encephalopathy. In: Bengtsson F, Jeppsson B, Almadal T, Vilstrup H, eds. Progress in Hepatic Encephalopathy and Metabolic: Nitrogen Exchange. Boca Raton, Ann Arbor: CRC Boston Press 1992; 41-47.
23. Maurer K, Lowitzsch K, Stöhr M: Evozierte Potentiale. AEP-VEP-SEP. Atlas mit Einführung. Stuttgart: Enke Verlag, 1990.
24. Dierks T, Maurer K: Reference-free evaluation of auditory potentials P300 in aging and dementia. In Dostert P, ed. Early Markers in Parkinson's and Alzheimer's Disease. Vienna: Springer Verlag 1990.
25. Picton T: The P300 Wave of the Human Event-Related Potential. J Clin Neurophys 1992, 9(4):456-479.
26. Meier R, Gyr K: Treatment of hepatic encephalopathy (HE) with the benzodiazepine antagonist flumazenil: a pilot study. Eur J Anaesthesiol Suppl 1988; 2:139-146.
27. Hamster W, Kluck M, Schomerus H: PSE- Syndrom-Test. Weinheim: Beltz Test Gesellschaft, 1985.
28. Weissenborn K: Neurophysiological methods in the diagnosis of early hepatic encephalopathy. In Bengtsson F, Jeppsson B, Almadal T, Vilstrup H, eds. Progress in Hepatic Encephalopathy and Metabolic Nitrogen Exchange. Boca Raton, Ann Arbor, Boston: CRC Press 1992; 27-39.
29. Duffy FH, Burchfield JL, Lambroso C: Brain electrical activity mapping: a method for extending the clinical utility of EEG and evoked potential data. Ann Neurol 1979; 5:309-321.
30. Campbell K, Marois R, Arcand L: Ethanol and the event-related potentials: effects of rate of stimulus presentation and task difficulty. Ann NY Acad Sci 1984, 425:551-555.
31. Kügler C, Petter J, Taghavy A, Lotterer E, Wensing G, Hahn EG, Fleig W: Dynamics of cognitive brain dysfunction in patients with cirrhotic liver disease: an event-related P300 potential perspective. Electroenc Clin Neurophysiol 1994; 91:33-41.
32. Ross BD, Farrow N, Kanamori K, Kreis R, Parivar F: Magnetic resonance techniques in hepatic: encephalopathy (HE). In: Bengtsson F, Jeppson B, Almadal T, Vilstrup H (Eds.): Progress in hepatic encephalopathy and metabolic nitrogen exchange. CRC Press, Boston, Bora Raton, Ann Arbor 1992:75-81.
33. Norton N, McConnell JR, Zetterman RK, Rodriguez-Sierra JF: A quantitative evaluation of magnetic resonance image signal changes of the brain in chronic hepatic encephalopathy. J Hepatol 1994; 21:764-770.
34. Hollerbach S, Kullmann F, Frv̈nd R, Geissler A, Lock G, Schölmerich J, Holstege A: Assessment of cognitive and morphologic brain abnormalities in patients with cirrhosis and portosystemic encephalopathy: Role of topographic evoked P300- evoked potentials and NMR- Spectroscopy. Gastroenterology (Abstract) 1996, 110(4): 537.
35. Hollerbach S, Tougas G, Kullmann F, Schölmerich J, Holstege A: Detection of (sub)clinical hepatic encephalopathy (HE) in cirrhotic patients by topographic event-related potentials (P300). Can J Gastroenterol 1996, 10 Suppl.A:47A (S107).
36. Madl C, Grimm G, Ferenci P, Kramer L, Yeganehfar W, Oder W, Steininger R, Zauner C, Ratheiser K, Stockenhuber F et al.: Serial recording of sensory evoked potentials: a noninvasive prognostic indicator in fulminant liver failure. Hepatology 1994;20:1487-1494.